epacadostat previously investigational drug epacadostat inhibitor indoleamine epacadostat inhibits competitively blocking without interfering tryptophan tdo antitumor activity models though effective combined immunotherapy combination epacadostat pembrolizumab keytruda investigated incyte merck co several cancers combination epacadostat nivolumab opdivo incyte bristol myers april incyte announced halting phase iii trial epacadostat pembrolizumab melanoma combination therapy missed first primary endpoint improving progressionfree survival vs pembrolizumab second primary endpoint overall survival yet httpsenwikipediaorgwikiepacadostat